AntibioTx is a privately held, clinical stage, pharmaceutical company dedicated to the development of a novel class of antibiotics with a new mechanism of action to treat bacterial infections and related disorders that are currently causing harm to millions of patients worldwide.

AntibioTx has a fully operational lab and has utilized cutting edge systems biology and screening methods to identify and characterize a potential game changing class of antibiotics.


The mission of AntibioTx is to develop and commercialize groundbreaking antibiotics with a novel mode of action to overcome antibiotic resistance and fight infectious diseases.


AntibioTx aspires to turn the Tx-class into the beta-lactams of the 21st century.

Learn more